nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alloantibodies and outcomes of deceased donor kidney allografts
|
Cinti, P. |
|
2009 |
70 |
8 |
p. 651-654 4 p. |
artikel |
2 |
Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study
|
Opelz, Gerhard |
|
2009 |
70 |
8 |
p. 627-630 4 p. |
artikel |
3 |
Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation
|
Taylor, Craig J. |
|
2009 |
70 |
8 |
p. 563-568 6 p. |
artikel |
4 |
Clinical relevance of complement-fixing antibodies in cardiac transplantation
|
Rose, Marlene L. |
|
2009 |
70 |
8 |
p. 605-609 5 p. |
artikel |
5 |
Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: The North Italy Transplant program approach
|
Poli, Francesca |
|
2009 |
70 |
8 |
p. 631-635 5 p. |
artikel |
6 |
Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: A risk factor
|
Gupta, Arun |
|
2009 |
70 |
8 |
p. 618-622 5 p. |
artikel |
7 |
Clinical significance of anti-HLA antibodies detected by Luminex ® : Enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools
|
Eng, Hooi Sian |
|
2009 |
70 |
8 |
p. 595-599 5 p. |
artikel |
8 |
Donor-reactive HLA antibodies in renal allograft recipients: Considerations, complications, and conundrums
|
Gebel, Howard M. |
|
2009 |
70 |
8 |
p. 610-617 8 p. |
artikel |
9 |
Emerging role of donor-specific anti–human leukocyte antigen antibody determination for clinical management after solid organ transplantation
|
Zeevi, Adriana |
|
2009 |
70 |
8 |
p. 645-650 6 p. |
artikel |
10 |
Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant
|
Claas, Frans H.J. |
|
2009 |
70 |
8 |
p. 636-639 4 p. |
artikel |
11 |
Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay
|
Phelan, Donna |
|
2009 |
70 |
8 |
p. 584-588 5 p. |
artikel |
12 |
Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant
|
Aubert, Vincent |
|
2009 |
70 |
8 |
p. 580-583 4 p. |
artikel |
13 |
Monitoring and treating posttransplant human leukocyte antigen antibodies
|
Everly, Matthew J. |
|
2009 |
70 |
8 |
p. 655-659 5 p. |
artikel |
14 |
Nebulous humors: Defining alloantibodies in the 21st century
|
Warner, Paul |
|
2009 |
70 |
8 |
p. 623-626 4 p. |
artikel |
15 |
Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: A Collaborative Transplant Study report
|
Süsal, Caner |
|
2009 |
70 |
8 |
p. 569-573 5 p. |
artikel |
16 |
Prospects and limitations of post-transplantation alloantibody detection in renal transplantation
|
Böhmig, Georg A. |
|
2009 |
70 |
8 |
p. 640-644 5 p. |
artikel |
17 |
Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival
|
Vlad, George |
|
2009 |
70 |
8 |
p. 589-594 6 p. |
artikel |
18 |
Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients
|
Stastny, Peter |
|
2009 |
70 |
8 |
p. 600-604 5 p. |
artikel |
19 |
Using real data for a virtual crossmatch
|
Zachary, Andrea A. |
|
2009 |
70 |
8 |
p. 574-579 6 p. |
artikel |
20 |
Which human leukocyte antigen antibodies are really clinically relevant?
|
Opelz, Gerhard |
|
2009 |
70 |
8 |
p. 561-562 2 p. |
artikel |